Fri. Nov 22nd, 2019

Teva says FDA-approved generic EpiPen is now available in the U.S. for $300 for a 2-pack

1 min read

Teva Pharmaceutical Industries Ltd.

TEVA, +4.68%

said Tuesday its FDA-approved generic version of the EpiPen is available in the U.S. at most retail pharmacies at a wholesale cost of $300 for a 2-pack. The news comes after a period of shortages for the EpiPen, a life-saving allergy treatment that is made by Mylan N.V.

MYL, +3.56%.

The Teva generic uses Antares Pharma

ATRS, -0.96%

VIBEX(R) device. Antares and Teva have an exclusive license, development and supply Agreement for epinephrine auto injector products that Teva markets in the U.S. Teva shares rose 0.6% premarket, but have fallen 57% in 2019, while the S&P 500

SPX, +1.21%

has gained 17″%.

Go to Source
Author: